NCT02363400 2025-08-19
A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA
National Health Research Institutes, Taiwan
Phase 3 Terminated
National Health Research Institutes, Taiwan
PhytoHealth Corporation
Institut Cancerologie de l'Ouest
Royal Marsden NHS Foundation Trust
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Northwestern University
Eastern Network of Cancer Immunological Therapy, Japan